ArticleCost effectiveness and resource allocation : C/E2021
Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making.
Article in Cost effectiveness and resource allocation : C/E, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 2 syntheses or guidelines pooled it, 52 citations in OpenAlex.
- Approaches to economic evaluations of complex interventions in thailand: a systematic review.BMC public health · 2025Pooled it
- Health technology assessment to support health benefits package design: a systematic review of economic evaluation evidence in Zambia.BMC health services research · 2024Pooled it
- Ethical Considerations in Health Technology Assessment for Precision Medicine: A Delphi Study in a Greek Setting.Journal of personalized medicine · 2026Article
- Harnessing health economic evaluation for policy and practice.Communications medicine · 2026Review
- Health technology assessment system in Tanzania: Is it a championing system or still a system lagging behind?PLOS global public health · 2026Article
- The Roles and Competencies of Nurse Managers in Enhancing Benefits and Lowering Barriers to the Implementation of Electronic Medical Records: A Mixed Methods Approach.Journal of healthcare leadership · 2026Article
- Exploring adaptive health technology assessment for evaluating 10 cancer interventions: insights and lessons from a pilot study in India.BMJ evidence-based medicine · 2025Article
- A systematic assessment of the demand for HTA hub services in Asia.International journal of technology assessment in health care · 2025Review
- Challenges in adopting health technology assessment for evidence-based policy in Iran: a qualitative study.Journal of health, population, and nutrition · 2025Article
- Navigating barriers to health technology assessment development in Iran: a qualitative exploration of stakeholder perspectives.Archives of public health = Archives belges de sante publique · 2025Article
- Calibration of transition probabilities to model survival of adjuvant trastuzumab for early breast cancer in Indonesia.International journal of technology assessment in health care · 2025Article
- Overcoming Barriers in Hospital-Based Health Technology Assessment (HB-HTA): International Expert Panel Consensus.Healthcare (Basel, Switzerland) · 2024Article
- Preparing future doctors for evidence-based practice: a study on health technology assessment awareness and its predictors in Malaysia.International journal of technology assessment in health care · 2024Article
- Topic identification, selection, and prioritization for health technology assessment in selected countries: a mixed study design.Cost effectiveness and resource allocation : C/E · 2024Article
- Exploring the landscape of health technology assessment in Iran: perspectives from stakeholders on needs, demand and supply.Health research policy and systems · 2024Review
- Disparate Digital Literacy Levels of Nursing Manager and Staff, Specifically in Nursing Informatics Competencies and Their Causes: A Cross-Sectional Study.Journal of healthcare leadership · 2024Article
- Health technology assessment (HTA) readiness in Uganda: stakeholder's perceptions on the potential application of HTA to support national universal health coverage efforts.International journal of technology assessment in health care · 2023Article
- Institutionalizing health technology assessment in Ethiopia: seizing the window of opportunity.International journal of technology assessment in health care · 2023Review
- Why cost-effectiveness thresholds for global health donors should differ from thresholds for Ministries of Health (and why it matters).F1000Research · 2023Article
- Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments.Current oncology (Toronto, Ont.) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 4 institutions in 5 countries.
Funding
Abstract
introductionDespite the documented benefits of using health technology assessments (HTA) to inform resource allocation in health care systems, HTA remains underused, especially in low- and middle-income countries. A survey of global health practitioners was conducted to reveal the top reasons ("excuses") that they had heard from colleagues, policymakers or other stakeholders for not using HTA in their settings.
methodsThere were 193 respondents to the survey. Most responses were from individuals in research organisations (37%), ministries of health (27%) and other government agencies (14%). Participants came from Southeast Asia (40%), the Western Pacific (30%), Africa (15%), Europe (7%), the Americas (7%) and the Eastern Mediterranean region (2%).
resultsThe top five reasons encountered by respondents related to lack of data, lack of technical skills for HTA, the technocratic nature of the work, the lack of explicit decision rules and the perception that HTA puts a "price on life".
conclusionsThis study aimed to understand and address the top reasons for not using HTA. They fall into three categories: (1) misconceptions about HTA; (2) feasibility issues; and (3) values, attitudes and politics. Previous literature has shown that these reasons can be addressed when identified, and even imperfect HTA analyses can provide useful information to a decision-maker.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.